Roots Analysis

FEBRUARY 13, 2023

Presently, more than 195 mRNA therapeutics / mRNA vaccines are under development or commercialized for the treatment of a variety of indications. For more details you can visit [link] The post mRNA Synthesis: ManufacturingProcess of Modern Revolutionary Molecule appeared first on Blog.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Roots Analysis

AUGUST 16, 2023

The success of COVID-19 vaccines paved the path for mRNA-based drug products. However, owing to the several challenges associated with the production of mRNA-based therapeutics / vaccines , majority of the pharmaceutical companies prefer to outsource their manufacturing operations.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

The Infectious Pharmacist

APRIL 6, 2021

Pfizer sent out a press release on March 31 with results from a small study of their mRNA vaccine in patients 12 through 15 years of age. The study enrolled about 2,200 patients with half getting the mRNA vaccine and half getting placebo. What about the Moderna vaccine? What about the vaccines in kids younger than 12 years old?

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 52

Roots Analysis

FEBRUARY 26, 2024

Given the robust pipeline of biologics, which include monoclonal antibodies, vaccines and other protein-based therapeutic products, subcutaneous medications are being investigated for various clinical candidates across different phases of development. You can also download the SAMPLE REPORT on subcutaneous medications by Roots Analysis.

Medication Delivery 52

Medication Delivery Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

Roots Analysis

MAY 21, 2024

Over the last decade, one of the major challenges faced by pharmaceutical companies across the globe is low drug solubility. In fact, it has been observed that around 40% of the pharmaceutical drugs approved by regulatory organizations exhibit poor bioavailability / solubility.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Immunization 40

Roots Analysis

FEBRUARY 20, 2022

Hence, many pharmaceutical companies outsource manufacturing of nanoparticles to third party organizations, called as contract manufacturers. Variety of services provided by contract manufacturers are as follows: Nanoparticles: Emerging Stars for Pharmaceutical Industry. Web: [link]. LinkedIn: [link]. Twitter: [link].

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

Roots Analysis

OCTOBER 3, 2023

Key Trends that are Shaping up the Global Bioreactors and Fermenters Market As per a recent market report by Roots Analysis, more than 255+ companies are currently involved in manufacturing bioreactors and fermenters, across the globe for the production of biopharmaceuticals, such as antibodies, vaccines, cell and gene therapies.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

Pharma Marketing Network

MAY 11, 2023

Pharmaceutical companies have made major strides in developing new treatments for Alzheimer’s disease, offering hope for the millions of people affected by this debilitating condition. Alzheimer’s is a progressive brain disorder that destroys memory and cognitive abilities, and currently there is no cure.

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

ISPE

SEPTEMBER 29, 2023

For more than 240 years, Takeda has focused on delivering transformative treatments in the therapeutic areas of gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling Patient Care 52

ISPE

SEPTEMBER 12, 2023

Empowered by Community; A Mentor ISPE Experience Trudy Patterson Tue, 09/12/2023 - 08:23 iSpeak Blog iSpeak Empowered by Community; A Mentor ISPE Experience Amy Washco 12 September 2023 As a mid-career employee, I’ve earned expertise in many areas but feel I still have much to learn. More importantly, I feel have much left to offer.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

Roots Analysis

SEPTEMBER 9, 2024

Over the years, pharmaceutical companies have shifted their priorities from traditional interventions towards more advanced pharmacological strategies, such as protein therapeutics. The post From Gene to Protein: The Journey of Protein Expression Technology appeared first on Blog.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines 40

Roots Analysis

AUGUST 13, 2024

mRNA-based therapeutics and vaccines have emerged as a promising alternative to conventional treatment approaches. Till date, four mRNA-based vaccines have received approval for the treatment of COVID-19, while a number of such candidates are being evaluated as potential therapies.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

Roots Analysis

JANUARY 24, 2024

For decades, pharmaceutical companies have manufactured drugs using batch processing in which a specific quantity of a drug is produced through multiple sequential steps. It is interesting to note that close to 50% of these companies are large and very large firms, indicating the presence of well-established players in this market.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Dosage Vaccines 40